
Complete Guide to Peptides for Fat Loss, Muscle Building & Longevity | Dr. Kyle Gillett MD
What this covers
Join Thrive Market Today to get 30% Off Your First Order AND a Free Gift Worth up to $60! http://ThriveMarket.com/ThomasDeLauer Complete Guide to Peptides w/ Dr. Kyle Gillett, MD
Follow Dr. Gillett on Instagram: https://www.instagram.com/kylegillettmd/ Be Sure to Check out Gillett Health here: https://gilletthealth.com/
This video does contain a paid partnership with a brand that helps to support this channel. It is because of brands like this that we are able to provide the content that we do for free.
Click HERE to Subscribe: https://www.youtube.com/c/ThomasDeLauerOfficial?sub_confirmation=1
Please check out the new Shorts channel, DeLauer Clips and Workouts, here: https://www.youtube.com/channel/UCQPQImPsw74KhO0Zy2-leyA/videos
Please Subscribe to my Email Newsletter Here: https://www.thomasdelauer.com/life-optimization-tactics/
Follow More of My Daily Life on Instagram: http://www.Instagram.com/ThomasDeLauer
Timestamps ⏱
0:00 - Intro 1:11 - Join Thrive Market Today to get 30% Off Your First Order AND a Free Gift Worth up to $60! 2:26 - Growth Hormone-Releasing Peptides (GHRP) 10:56 - Vascular Endothelial Growth Factor (VEGF) 15:20 - Growth Agonists 20:39 - Melanocortins 27:33 - Amylin 30:55 - GLP-1 33:02 - SARMs 37:45 - Where to Find More of Dr. Gillett's Content
Source description (no synthesized summary yet).
Kyle Gillette provides a comprehensive classification and clinical framework for understanding peptides by therapeutic class rather than regulatory status, emphasizing that peptide selection requires matching specific mechanisms to individual health contexts, contraindications, and risk-benefit profiles rather than using a one-size-fits-all approach.
- Peptides should be categorized by mechanism (GHRPs, VEGF agonists, growth factors, melanocortin agonists, amylin, GLP-1s) not by whether they're medications or supplements, as this reveals distinct use cases and contraindications
- Safe use requires understanding both benefits and risks: tumor risk with growth hormone agonists, VEGF-related cancers, sexual side effects with melanotans, and SHBG suppression with SARMs demand patient screening and ongoing monitoring
- Most peptides are used off-label with limited clinical trial data, requiring clinicians to prioritize lower theoretical risk profiles and familiarity with historical use rather than long-term continuous protocols
This asset isn't compiled yet
You're seeing its claims, ranked. Compile it to build the argument threads, weight them, and check each claim against your library — the full view.
Hypoactive sexual desire disorder is a subjective diagnostic category with significant individual and contextual variation; sexual desire appropriateness depends on life circumstances (postpartum period, attempts to conceive, etc.) and partner considerations, so peptide therapy should only be considered after determining whether low desire is truly pathological.
“there is a huge Gray Zone and it also depends on who your partner is so as an example as someone who's had two kids and have also delivered a couple hundred babies I'm familiar with how you might want to have a different sex drive when you're in when your family's in the postpartum period versus when you're trying to get pregnant versus different times in your life so that's something that you should that everybody should talk to their doctor about”
Most GHRP peptides (ghrelin agonists, GHRH analogs, BPC-157, TB-500, GHK copper peptide) lack FDA-approved indications and are used entirely off-label, so when off-label use occurs, clinicians should prioritize compounds with the lowest theoretical risk profiles and the longest histories of clinical use rather than novel compounds.
“by the way bpc157 GHC copper peptide and tb500 are always used off label there's no approved indication whereas for a lot of these classes in fact um approved on label indications yes yes yes yes yes yes but these two do not however theoretically they're some of the lowest risk so whenever there's not an approved indication and it hasn't been through all three stages of clinical trials and gotten approved then you want the theoretical risks to be as low as possible and you also want to be familiar with um how it's been used in the past”
GHRP-induced hyperglycemia occurs independent of increased eating, as evidenced by continuous glucose monitors showing elevated glucose levels throughout the day even when food intake is controlled
“even independent of eating more we know that you do have transient acute hyperglycemia so if you follow it along with your CGM then it's not unusual to see glucose higher throughout the day”
The limbic system contains multiple 'positive switches' required for libido and sexual function—including leptin, alpha-melanocyte-stimulating hormone (α-MSH), and others—and sun exposure increases endogenous α-MSH release from melanocortin receptors, explaining why Brazilians report increased sexual activity during the hottest months.
“within the limbic system there's a lot of different what I call positive switches so in order to have libido you have to have all these switches on and in fact in order to go through puberty you have to have all these switches on leptin is one of the switches so leptin is one of the reasons why when you're very lean um you might have less but a m s h is another one alpha it should be a lowercase Alpha because it's a Greek Alpha msh and this is what normally binds melanocordine receptors”
GHRPs (growth hormone releasing peptides) function through two distinct mechanisms: ghrelin agonists that bind G protein-coupled receptors in the pituitary to stimulate pulsatile growth hormone release, and GHRH analogs that work on a different pituitary receptor, allowing synergistic low-dose combinations that reduce side effects while maintaining efficacy.
“ghrelin binds a g protein coupled receptor in the pituitary and that helps the body release more growth hormone pulsately so it is a growth hormone releasing peptide”
Melanoma risk from melanocortin agonists is contraindicated in people with family history of melanoma, dermatotypes with high intrinsic risk (red hair, freckles, pale skin), or history of 10+ severe sunburns, as these individuals already have significantly elevated melanoma risk.
“if you have any family history of melanoma or if you have a dermatotype for example red hair and a lot of freckles and pale skin significantly increased risk of melanoma or if you've just had a really a lot of really bad sunburns let's say you've had 10 um severe sunburns throughout your life you're also at increased risk of melanoma then I consider that a contraindication for Millennial cord and receptor agonists”
SARMs (Selective Androgen Receptor Modulators) are increasingly progressing through clinical trials for oncological indications, particularly ostarine (MK-2866, rebranded as Enobosarm) for triple-negative androgen receptor-positive breast cancer and prostate cancer, where they inhibit the adrenal androgen synthesis cascade without the systemic virilization of exogenous testosterone.
“ostern which is mk2866 continually progresses forward in the clinical literature when it comes to to what's called Androgen receptor responsive breast cancer which is actually extremely rare it's usually triple negative so er negative PR negative her22 her2 new negative but you think about the benefits of that in an individual who has breast cancer prostate cancer would be the other potential indication”
Clinical trial data for peptides often shows flashing on-and-off benefits because many have only completed Stage 2 or Stage 3 trials without full FDA approval, creating uncertain risk-benefit profiles
“when it comes to um the I guess long-term use of these growth agonists my main concern would be tumor growth I just feel like there's not enough of a um and by the way bpc157 GHC copper peptide and tb500 are always used off label there's no approved indication whereas for a lot of these classes in fact um approved on label indications yes yes yes yes yes yes but these two do not however theoretically they're some of the lowest risk so whenever there's not an approved indication and it hasn't been through all three stages of clinical trials and gotten approved then you want the theoretical risks to be as low as possible”
Pramlintide's poor adherence (three daily injections) limits practical utility compared to lifestyle interventions, making long-acting formulations strategically important for diabetic populations
“this compared to this uh this you're not gonna have good adherence three times a day injections for someone that's not uh if you if you're a type 1 diabetic then perhaps you have good adherence because your life depends on it um but really your life more depends on the insulin”
Contraindications to GHRP use include active tumors (benign or malignant), family history of cancer, and risk of hyperglycemia and insulin resistance, requiring patients to undergo aggressive preventive screening with diagnostic imaging and early cancer detection protocols before initiation.
“part of it depends on if they have a relative contraindication contraindications in my mind would be active tumor benign or malignant chance of an active tumor benign or malignant so they want to have aggressive preventive screening both with Diagnostic Imaging and advanced like early cancer detection and also risk of hyperglycemia and insulin resistance”
Copper deficiency is common after bariatric surgery (gastric bypass or biliary pancreatic diversion) at approximately 10 years post-op, and board-certified bariatricians routinely screen copper levels because deficiency can cause bicytopenia (low white and red blood cells).
“you um that is indeed copper so let's say you've had bariatric surgery and you're not able to absorb copper well about 10 years after gastric bypass or biliary pancreatic diversion it's very common to see deficient copper levels that's why any board-certified obesity medicine physician or bariatrician will check a copper level so that's another thing to watch out for another Fringe benefit or if you have anemia low white blood cells or low red blood cells but you do not have a deficient B12 folate or iron copper is probably another thing you want to check it can cause bicytopenia”
CJC (a GHRH analog) had its clinical trial in Brazil stopped due to a reported death, which is why Gillette personally prefers tessomorelin (Tesamorelin), which has recently received FDA approval for three different indications.
“CJC is one of these I believe it's 12.95. um let's see sir Moreland is another one sir Moreland and then uh sarcotropin is another one there's a whole bunch of ghra analogues and a whole bunch of grelin agonists as well but in general my go-to is Tessa morelin occasionally some Orleans some moreland's been around the longest and it was one of the first to go through this different stages of clinical trials but now is used less just because Tessa Moreland has recently gotten FDA approval I believe for three different indications”
Avastin (bevacizumab), a VEGF-blocking chemotherapy drug, is prescribed because cancers overexpress VEGF and are heavily vascularized; thus, peptides like BPC-157 that increase VEGF and blood flow are contraindicated in anyone with active malignancy because they would feed tumor growth.
“I often mention the medication avastin a-v-a-s-t-i-n which blocks veg F so it's the opposite of bpc157 and it is a essential chemotherapy medication so it's prescribed for many different types of cancers cancers tend to overexpress vegf and they tend to be well vascularized so you don't want to send even more blood flow to something that's so hungry for blood flow that it's growing”
Bremelanotide (PT-141, Vylesi) is FDA-approved only for hypoactive sexual desire disorder in females despite working equally well in males, and it works by activating α-MSH and melanocortin receptors in the limbic system to enhance sexual arousal and spontaneous erections.
“bremelanotide this one uh also known as violisi is indicated for hypoactive sexual disorder whatever that is so that's obviously a very relative thing hypoactive hypoactive sexual disorder and oddly enough um it's only indicated in females although for sure it works on both females and males”
Melanocortan receptor agonists cause side effects including nausea, increased skin tanning and darkening, and loss of photo-bleaching (natural hair lightening) in blonde individuals, but do not cause downregulation or loss of efficacy with continued use.
“it can stop that one sounds kind of kind of interesting nausea is a side effect for all these and in fact for all of these becoming more tan so a darker skin tone and loss of photo bleaching of the hair so if you're like a dirty blonde that has the photo bleaching effect then often you lose that as you start to utilize any of these even the fourth generation which is set melanotide”
Amylin is a peptide co-produced with insulin by pancreatic beta cells and is indicated for treatment of type 1 and type 2 diabetes; synthetic amylin (pramlintide/Symlin) has a very short half-life requiring three daily injections and is weight-negative through potentiation of insulin's glucose-lowering effects.
“amelin is another peptide that's made by the pancreas that's specifically the beta cell so in your pancreas you have your Alpha cell and you have your beta cell these are your Endocrine cells of the pancreas and your islets of langerhans and none of that really matters that much but the takeaway from this is It's indicated in diabetes including type 1 diabetes and it is very weight negative”
Pro-insulin to insulin ratio is a marker of beta-cell dysfunction and impending pancreatic beta-cell death across all diabetes types and severe insulin resistance, even when absolute insulin levels are also elevated
“if you're pro-insulin is high even if you do not have type 1 diabetes if you have type 1.5 or if you have type 2 diabetes or if you just have really severe insulin resistance if your pro insulin is high and your insulin is relatively low compared to that even if it's also High then that is a sign of impending pancreatic death”
TB-500 (thymosin beta 4) and GHK-copper peptide are derived from thymus and liver respectively, and young children heal quickly because they have functional thymi and well-functioning livers, whereas older individuals lack thymic function and hepatic decline—these growth agonists provide targeted benefits similar to systemic growth hormone but with less risk
“thymus in beta 4 comes from the thymus ghk copper peptide comes from the liver they're one reason why say young children with a thymus and a very well functioning liver can heal very quickly whereas older individuals that do not have a thymus and do not have a well-functioning liver cannot so I think of these as more targeted with similar benefits but with less risk than the shotgun approach of increasing growth hormone everywhere”
Oxandrolone (Anavar), despite popular belief, causes hypothalamic-pituitary suppression (shutdown); it is not a consequence-free androgenic compound and should be used judiciously, not casually.
“I've even heard people say there's no shutdown with oxandrolone which is anavar yeah and yes um that also causes hypothalamic and pituitary suppression which is shut down so it's not something that you should take but it's something that you could be excited about”
Melanocortin agonists have fast half-lives and work quickly (within minutes for injectable formulations), so they are not required to be used continuously and can be dosed as needed, with no tolerance development or libido loss upon discontinuation.
“these all have uh fast half-lifes so it's something that if someone is if someone is using it specifically for that reason and they're you know it's one of the being a fast Half-Life it works quick”
Growth hormone was once viewed as the primary anti-aging molecule 30 years ago but is actually pro-aging because it accelerates cell aging and cell turnover, so targeted growth agonist peptides offer benefits of growth factor signaling without the systemic aging acceleration.
“about 30 years ago the medical community went through a phase of um they thought growth hormone is the um you know the answer the de facto anti-aging molecule although it literally does accelerate cell aging and cell turnover so it's actually kind of a pro-aging molecule but anyway it's a strategy to get some of the benefits from here without all the risks”
GHRP-induced diabetes, which can occur with compounds like ibutamorin (MK-677), is reversible upon discontinuation and mechanistically similar to gestational diabetes, since both are caused by growth hormone-like hyperglycemic signals (gestational diabetes from human placental lactogen) rather than pancreatic beta cell failure.
“there's actually clinical clinical literature published that shows cases of ghrp-induced diabetes reversible when you stop the ghrp specifically I believe with ibutamorin which is mk677 I call it ghrp diabetes and it is almost identical to gestational diabetes because if you think about gestational diabetes which is when a pregnant lady does a glucose tolerance test and would normally be diagnosed with diabetes but it's because of something called hpl which is human placental lactogen it's very similar it's very analogous to growth hormone itself”
For approximately 98% of non-diabetic individuals with obesity and mild metabolic syndrome, semaglutide (GLP-1) is the most potent medication needed; more powerful GLP-1/GIP combination agonists (like tirzepatide/Mounjaro) and triple agonists are unnecessary and create an 'arms race' of escalation driven by pharmaceutical competition rather than clinical need.
“however whether or not they're necessary in the average individual that has obesity and a touch of metabolic syndrome they're probably not necessary what's necessary is addressing other mechanisms or other vectors of why they are obese mostly lifestyle yeah for the average for I'd say for 98 of people that don't have diabetes you do not need anything more powerful than semi-glutide to help your lifestyle interventions work”
GLP-1 receptor agonists like semaglutide should be prescribed at one-fifth to one-tenth of the maximum dose in most obese patients rather than at approved doses, because lower doses serve as 'training wheels' that facilitate lifestyle habit formation (diet, exercise, sleep) without suppressing appetite so much that patients cannot learn sustainable behaviors.
“for a lot of individuals that are obese they don't even need some glue type in fact they do better without it because harder to learn the habits that cement good diet exercise and sleep practices in when you're covering that up with some glutide so when I do prescribe glp ones often I do at one-fifth the maximum dose or even one tenth the maximum dose so it's much easier to get off”
BPC-157 dosing should follow a short-term, finite protocol of 2-3 times weekly for 2-6 weeks, not continuous long-term use, and if no improvement is seen within 2-4 weeks it is unlikely to work for that particular indication.
“most dosing regimens are subcutaneously administered and it's usually two to three times a week for two to six weeks and I have seen excellent results of this anecdotally as I've mentioned on the Gillette Health podcast with my own experience using bpc157 for my shoulder and also it's in it in my leg but I've seen it with hundreds of patients as well but inevitably we will get comments on this video from people that say you're under dosing bpc157 you need to use it continuously all the time and that's just not the case”
The optimal IGF-1 range for longevity and health is between 100-250 ng/mL, as this balances benefits of growth factor signaling against risks of tumor growth, hyperglycemia, insulin resistance (at higher levels) and sarcopenia, increased adiposity, and intramuscular triglyceride accumulation (at lower levels), with age-specific adjustments required.
“my general rule of thumb is an igf-1 between about 100 and 250 is the Goldilocks zone not so high that you're at risk of tumor growth and hyperglycemia and insulin resistance and not so low that you're at risk of sarcopenia and increased adiposity increased intramuscular triglyceride Etc”
BPC-157 (body protective compound) is the only known angiogenic peptide and works by triggering the release of VEGF through capillary leakiness at injury sites, allowing plasma and growth factors to leak into tissue similar to platelet-rich plasma, which is why heat promotes healing while ice impairs it by constricting capillaries and preventing VEGF delivery.
“bpc157 is the only peptide that I know that is angiogenic it's a body protective compound and it's made in higher levels endogenously by those with that have healthy guts and stomachs so vegf is technically a cytokine so you think about what cytokines do if you have inflammation if you have an injury in your shoulder then um your capillaries will become leaky it'll leak plasma”
SARMs suppress hypothalamic-pituitary-gonadal (HPG) axis output of luteinizing hormone (LH) and suppress sex hormone-binding globulin (SHBG), which can paradoxically increase free androgens and free estrogens despite lower total hormone levels, and compounds like LGD-4033 and RAD-140 commonly drive SHBG to critically low levels (2-3 ng/mL), impairing regulation of estrogen and androgen metabolism.
“sarms do a couple things one is that they do slightly suppress a hypothalamic and pituitary gonadotropic output so think of LH in that case they do slightly suppress it but mostly they're going to increase the metabolism of testosterone and anything that's related to shbg because you have a very low shpg It's Not Unusual to see an shpg especially with ligandrol which is lgd or rad 140 It's Not Unusual to see an shbg of 3 or even two”
Low back injuries and disc issues show some clinical benefit from BPC-157, though the effect is less dramatic than with shoulder tendons or knee injuries; some patients experience no benefit despite proper dosing.
“asking for a friend low back injuries disc issues any anecdotal experience there yes there is some experience it it's not quite the same precipitous effect that I see with various tendons in the shoulders sometimes the meniscus sometimes tendons in the knee but I have I have had good luck with that as well in general I say if you try it and you don't notice anything in the first two to four weeks it's just not going to work because I've also seen cases where it has not helped at all”
Best candidates for growth agonist peptides are individuals who would otherwise need different forms of intervention or whose profession depends on performance; general aches and pains represent secondary benefits rather than primary indications
“the best candidate is someone who would otherwise need a different form of intervention or who wants to get back and let's say their profession depends on their performance um on that note I do believe bpc157 I don't know if it was wada or usada but I believe it's on one of those two lists as of within the last year”
Thymus-derived peptides like thymosin alpha-1 are sometimes used as immune system boosters but show poor clinical data and unclear risk-benefit profiles, so Gillette does not recommend their use despite anecdotal interest in immunity enhancement.
“I know that the uh thymus related peptides have been used for other indications as well like immunity and anecdotally I have not seen seen good success with that so other ones like thymuscene Alpha One yeah okay and that's one that's typically given like what is like kind of a bolus of the immune system right correct so and just not good data on it or it's just not create data and the risk benefit profile isn't really there when it comes to this scale”
Substantia is a natural SARM-like compound under investigation, but its tissue selectivity profile is poorly understood ('terrifying'), making caution appropriate until more data emerges.
“there's a couple things that I'm looking at substantia is one of them that's probably a naturalist arm we just don't know which tissues it's active in which is kind of terrifying um so you sh if you're terrified of sarms then you should be”
Growth hormone deficiency can occur at any age, including in younger individuals, not just in older people, and pediatric growth hormone deficiency is a studied indication for GHRP therapy.
“typically someone that's an older person that's maybe they're not producing as much you see that in younger people as well you can see it in either age and in fact many of these have been studied for indications of pediatric growth hormone deficiency”
Insulin is described as Gillette's favorite peptide because it is life-saving, and bioidentical human insulin (as opposed to recombinant variants) preserves the native amino acid sequence required for physiological glucose homeostasis.
“amylen is the other thing that's made by the beta cell that has not really been replaced we've tried a lot so pram limitide is one of them different marker yeah similin is the other name so synthetic amylin is Similan or paramelinatide tide so this one is a very short half-life and it's injected three times a day and we even played around people are familiar with insulin pumps they also tried to put this in an equal ratio with an insulin pump because let's say you have type 1 diabetes you have an auto antibody you've destroyed all your beta cells you can essentially make exogenous beta cells in artificial pancreas and artificial pancreases are coming by the way but you can make a version of an artificial pancreas where you have a pump that releases both insulin and amylin in the same ratio that way type 1 diabetics that take a lot of insulin don't tend to gain so much weight so amylen is a potentiator when it comes to insulin it's going to lower blood glucose and it's going to cause weight loss which is why there's companies like Eli Lilly and others that are studying a Next Generation you have what's called long-acting ambulin long acting so these you inject once a week long acting ammo and analogs and you use them with glp ones so um this compared to this uh this you're not gonna have good adherence three times a day injections for someone that's not uh if you if you're a type 1 diabetic then perhaps you have good adherence because your life depends on it um but really your life more depends on the insulin but if you're someone that has uh insulin resistance and beta cell death which one way to know that is your ratio of pro-insulin to insulin if you're pro-insulin is high even if you do not have type 1 diabetes if you have type 1.5 or if you have type 2 diabetes or if you just have really severe insulin resistance if your pro insulin is high and your insulin is relatively low compared to that even if it's also High then that is a sign of impending pancreatic death so if your insulin is relatively low then you can use an Amal and analog and it will greatly decrease your use of insulin so the best clinical use in this scenario is a diabetic of any type that their beta cells are going to die anyway they have no chance of getting off insulin unless they have some ambulin to help re-insulin sensitize them they're a great candidate for it interesting okay and these work well with glps which I know a lot of people are familiar with but maybe there's some other outside of just uh the basic ones we've talked about before yep semiglutide is kind of the main one there's a combined glpgip that is terzapatide serves up a tide that's munjaro and then there's a Lyra glutide which I like a lot that is going to be generic soon the uroglutide and there are several others there's even a triple Agonist so we talked about in cretins before there is a triple Agonist that's not just glp-1 not just Gip and I don't think it's dpp4 it's a different ingredient effect but there's a lot more of these that are more and more powerful we'll see in an arms race of race of X of escalation however whether or not they're necessary in the average individual that has obesity and a touch of metabolic syndrome they're probably not necessary what's necessary is addressing other mechanisms or other vectors of why they are obese mostly lifestyle yeah for the average for I'd say for 98 of people that don't have diabetes you do not need anything more powerful than semi-glutide to help your lifestyle interventions work and for a lot of individuals that are obese they don't even need some glue type in fact they do better without it because harder to learn the habits that cement good diet exercise and sleep practices in when you're covering that up with some glutide so when I do prescribe glp ones often I do at one-fifth the maximum dose or even one tenth the maximum dose so it's much easier to get off got it it's like training wheels you don't want to have your training wheel stabilize your bike too much you'll never learn how to ride it yourself that makes perfect sense”
Lipodystrophy (excessive visceral abdominal fat) is a clinical indication for ghrelin agonist therapy because these compounds help mobilize and reduce pathological fat accumulation.
“the use case is things like borderline growth hormone deficiency or growth hormone deficiency there's also use cases in things like lipodystrophy you have huge amounts of abdominal body fat visceral abdominal body fat and you want to decrease the amount of that body fat”
PT-141 (bremelanotide) can serve as a useful complement to other sexual health optimization measures but should not be the only intervention; combined approaches addressing partner dynamics and life circumstances are more holistic.
“with the pt141 it does stacked nicely with other Sexual Health optimization measures”
Ghrelin was discovered by reverse-engineering the mechanism of known synthetic ghrelin agonists (ibutamorin, ipomorelin) that bound pituitary G-protein coupled receptors; scientists looked for the endogenous ligand of this receptor and identified ghrelin.
“in fact we discovered ghrelin because we knew that these the ghrelin agonists like IPO morelin or ibutamorin would bind that receptor in the pituitary and we looked for what the endogenous equivalent of that was and it happens to be growing interesting”
Terzapatide (Mounjaro) is a GLP-1/GIP dual agonist that combines effects of semaglutide (GLP-1 only) with additional GIP receptor activation, providing more potent glucose lowering and weight loss than GLP-1 monotherapy.
“there's a combined glpgip that is terzapatide serves up a tide that's munjaro”
BPC-157 is prescribed topically at injury sites or orally in capsule form for gastrointestinal conditions like Crohn's disease, with oral absorption bypassing hepatic first-pass metabolism.
“occasionally it's prescribed in versions of capsules for individuals with things like Crohn's disease but similar to ghrhs really these first three categories one of the major risks is going to be tumor growth”
Gillette is personally optimistic about SARMs for future prostate cancer treatment because of his family history of early-onset prostate pathology; if diagnosed with prostate cancer, he hopes to maintain body composition, athletic performance, and healthspan through selective androgen receptor modulation, even in metastatic disease.
“I'm excited about it given my family history of prostate cancer prostate pathologies at Young ages I hope that if at one point when I'm older I got prostate cancer that these are my best chance to maintain quality of life to maintain a low body fat percentage to maintain uh decent athletic performance and a decent Health span even if I actively have uh prostate cancer or even metastatic prostate cancer”
Liraglutide (another GLP-1 receptor agonist) is a formulation Gillette particularly favors and is expected to become generic soon, making it more accessible than semaglutide for patients.
“there's a Lyra glutide which I like a lot that is going to be generic soon the uroglutide”